Home›People›Monique Schiersing
Monique Schiersing

Monique Schiersing

Senior Investment Director, Roche Venture at Bonum Therapeutics.

Director
Updated Nov 10, 2026·Latest SEC filing Apr 17, 2026·Suggest an edit

About Monique Schiersing

Monique Schiersing is a senior investment director, roche venture at Bonum Therapeutics.

Monique Schiersing first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Monique Schiersing in the role, so the role may have started earlier or lasted longer.

Bonum Therapeutics, Inc.
Senior Investment Director, Roche Venture
2021 – 2026 · Seattle, WA
Develops targeted protein medicines for people with cancer.

Key Colleagues at Startups

The people Monique Schiersing works with at each company, as listed on that company's latest Form D.

Bonum Therapeutics, Inc. · Form D, Apr 17, 2026
Samuel Bjork
Samuel Bjork
Executive Chair
Neela Patel
Neela Patel
Chief Business Officer
JM
John McKearn
Director
Diane Hollenbaugh
Diane Hollenbaugh
Chief Scientific Officer
Samuel Blackman
Samuel Blackman
Independent Director
John Mulligan
John Mulligan
Chief Executive Officer and director
Karl Handelsman
Karl Handelsman
Founder & Managing Partner, Codon Capital, director
NW
MM
Mitchell Mutz
Independent Director
Gaurav Aggarwal
Gaurav Aggarwal
Managing Partner, Vivo Capital and director

Sources

  1. SECBonum Therapeutics, Inc. Form D, filed Apr 17, 2026